Polypharmacy — conventionally defined as the concurrent use of five or more medications — is prevalent among patients with Type 2 Diabetes Mellitus (T2DM) and is associated with adverse drug interactions, treatment non-adherence, and escalating healthcare costs. Integrative management programmes combining Panchakarma-based therapies, structured dietary intervention, and allopathic co-management have shown promise in glycaemic control, yet their impact on medication burden has not been systematically characterised.
Reduction in Polypharmacy Burden Among Type 2 Diabetes Mellitus Patients Through Comprehensive Diabetes Care Plan-Based Integrative Management: Implications for Adverse Drug Interaction Risk and Health System Cost
Medically Reviewed By
Dr. Rohit Madhav Sane
M.B.B.S, Fellowship in Cardiology
Founder & CEO
Last Updated
29 Jun 2026
About The Author
Dr. Rohit Madhav Sane
Dr. Rohit Sane is a physician, preventive cardiology expert, and Founder & Managing Director of Madhavbaug. With over 20 years of experience, he has led efforts to combine evidence-based Ayurveda with modern medicine. He focuses on preventing and managing lifestyle diseases, especially cardiovascular disorders. He is a recognized healthcare entrepreneur, researcher, and advocate of preventive healthcare in India.
Locate a CentreFind a Madhavbaug Centre Near You
With over 300+ clinics and specialized hospitals across India, find expert reversal care right in your neighborhood.
Disclaimer
The content on this website is for informational purposes only and should not be considered a substitute for medical advice. Please consult a qualified Madhavbaug Ayurvedic doctor before starting any treatment.
Start Your Journey to a Medicine-Free Life with Madhavbaug
Don't just manage your condition. Overcome it. Take the first step toward sustainable, evidence-based chronic disease reversal.